Merck Leads the Dow Jones Today Higher as Low-Income Patient Subsidies End

Health care stocks are leading the Dow Jones today as Merck moves to end uncertainty over Obamacare.

Mar 26, 2014 at 1:31PM

The Dow Jones Industrial Average (DJINDICES:^DJI) is up despite mixed reports on the U.S. economy. Merck (NYSE:MRK) is leading the Dow higher after the company said it would no longer subsidize expensive drugs for low-income patients on Obamacare. As of 1:30 p.m. EDT the Dow was up 41 points to 16,409. The S&P 500 (SNPINDEX:^GSPC) was up 11 points to 1,767.

The Dow today is up with 22 of 30 components positive for the day after there were two U.S. economic releases.





Durable goods orders




Durable goods orders Ex-transportation




Markit non-manufacturing flash PMI




Both reports were mixed. The Commerce Department reported durable goods orders came in well above analyst expectations of 1% growth. If you exclude the transportation sector, which includes the volatile jetliner and automobile markets, the numbers don't look nearly as good. Durable goods orders ex-transportation were up just 0.2% in February, below January's 0.9% growth and below analyst expectations of 0.2%. The low number was the result of a 2.8% drop in spending on capital goods, that is the assets businesses use in their production. A drop in capital goods signals lower business spending across the board.

The other report was Markit's advance look at its services purchasing managers index. The index rose to 55.5, above last month's 53.3, signaling a faster expansion in economic activity than last month.


Source: Markit.

While the index is up, a measurement of 55 indicates GDP growth of roughly 2.5%, well below what would be considered desirable in a low interest rate environment. The other slightly worrisome sign was that the measure of new business fell to its lowest level since late 2012, signaling business growth may be slowing. Both these reports are important in that they tell us that the economy's slow growth story continues.

Today's Dow leaders
Today's Dow leader is Merck, up 2.2% to $56.40. Merck and GlaxoSmithKline said they will no longer subsidize expensive drugs for low-income patients on Obamacare. The two pharmaceutical giants are taking this action after a prolonged debate over whether the subsidies are legal. Two regulators, U.S. Department of Health and Human Services and the Centers for Medicare and Medicaid Services, have issued differing opinions over the matter.

 Other Dow pharmaceutical giants Pfizer and Johnson & Johnson (NYSE:JNJ) are also up today. Johnson & Johnson told Bloomberg it thinks the payments are legal. While some attribute Merck's rise today to not paying the subsidies, by that logic Pfizer and Johnson & Johnson should not be up. I suspect the companies are all up as investors see this move by Merck and GlaxoSmithKline as forcing the government into finally ending the uncertainty over the matter. Businesses and investors alike do not like uncertainty and so an end of uncertainty on the matter will be a boon to investors in all of the health care giants, especially those dealing with Obamacare.

Everything you need to know about Obamacare
Obamacare seems complex, but it doesn't have to be. In only minutes, you can learn the critical facts you need to know in a special free report called "Everything You Need to Know About Obamacare." This FREE guide contains the key information and money-making advice that every American must know. Please click here to access your free copy.

Dan Dzombak has no position in any stocks mentioned. The Motley Fool recommends Johnson & Johnson. The Motley Fool owns shares of Johnson & Johnson. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information